Patrys (ASX:PAB) ROE % Adjusted to Book Value : -27.93% (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Patrys ROE % Adjusted to Book Value?

Patrys's ROE % for the quarter that ended in Dec. 2024 was -111.70%. Patrys's PB Ratio for the quarter that ended in Dec. 2024 was 4.00. Patrys's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -27.93%.

Patrys ROE % Adjusted to Book Value Historical Data

The historical data trend for Patrys's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Patrys ROE % Adjusted to Book Value Chart

Patrys Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-19.05

-6.03

-18.62

-20.93

-19.62

Patrys Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-12.38	-22.85	-16.46	-21.37	-27.93

Competitive Comparison of Patrys's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Patrys's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Patrys's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Patrys's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Patrys's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Patrys ROE % Adjusted to Book Value Calculation

Patrys's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-68.67%	/	3.50
	=	-19.62%

Patrys's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-111.70%	/	4.00
	=	-27.93%

Patrys ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Patrys's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Patrys Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Patrys Ltd (ASX:PAB) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Level 4, 100 Albert Road, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.patrys.com

Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 PAT-DX1-NP, PAT-DX3, and PAT-LM1. Its main technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody that penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.